Current Therapeutic Approaches for Early-Stage HER2-Positive Breast Cancer

Download this slideset with key data on optimal adjuvant therapy and extended adjuvant therapy for patients with early-stage HER2-positive breast cancer. Experts discuss how to identify which patients are most likely to benefit from the available treatment strategies.

Share

Program Content

Activities

Current Treatment Options for HER2+ EBC
Current Therapeutic Approaches for Early-Stage HER2-Positive Breast Cancer: Aligning Practice With Expert Consensus
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: April 25, 2019

Expires: April 23, 2020

Faculty

cover img faculity

Sara Hurvitz, MD

Assistant Professor of Medicine
Director, Breast Oncology Program
Division of Hematology-Oncology
Department of Internal Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

cover img faculity

Hope S. Rugo, MD

Clinical Professor of Medicine
UCSF Comprehensive Cancer Center
University of California, San Francisco
San Francisco, California

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Puma Biotechnology, Inc.